申请人:Sarepta Therapeutics, Inc.
公开号:US11000600B2
公开(公告)日:2021-05-11
Antisense oligomer conjugates complementary to a selected target site in the human dystrophin gene to induce exon 53 skipping are described.
本研究描述了与人类肌营养不良症基因中选定的目标位点互补的反义寡聚体共轭物,以诱导第 53 号外显子跳越。